JPRN-UMIN000004613已完成未知
Prospective research of the biomarkers associated with adjuvant chemotherapy in patients with resectable biliary tract cancer - A research of the biomarkers associated with adjuvant chemotherapy in patients with resectable biliary tract cancer
Department of Medical Oncology, University of Miyazaki Hospital0 个研究点目标入组 50 人开始时间: 2010年11月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Intestinal pneumonia or lung fibrosis 2) No previous adjuvant therapy 3) Severe diarrhea 4) Severe mental disorder 5) Active infection 6) Severe complication disease 7) Sever postoperative complications 8) History of chest radiotherapy 9) intractable pleural or abdominal effusion 10) Distant metastasis 11) History of other active malignancy 12) Pregnacy or patient's hope to be pregnant 13) Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
招募中
不适用
An exploratory prospective study of the biomarkers of the immune-related adverse events (irAE) and the mechanisms of irAE in solid cancer patients treated with Pembrolizumab.solid cancerJPRN-UMIN000028474Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine.30
招募中
不适用
Prospective observational study of biomarkers to predict efficacy after Nivolumab in patients with previously treated advanced non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000020823Gunma University30
未知
不适用
Prospective observational study of biomarkers to predict efficacy after Pembrolizumab in patients with PD-L1 positive advanced non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000026793Gunma University50
尚未招募
不适用
A prospective observational study of biomarkers for Second-line FOLFIRI plus Aflibercept treatment in patients with metastatic colorectal cancer comparing to FOLFIRI plus beVacizumab: an Exploratory biomarker study.colorectal cancerJPRN-UMIN000038508Kyoto University Hospital70
已完成
不适用
Prospective study for predictive biomarkers and modified risk scoring model for venous thromboembolism in Japanese patients with unresectable or metastatic cancer.lung cancer, esophageal cancer, gastric cancer, biliary tract cancer, pancreatic cancer, colorectal cancerJPRN-UMIN000026826Clinical Research Center, Saga University Hospital240